Olpasiran Outperforms Other Subcutaneous Lipoprotein(a)-Lowering Agents in Efficacy and Safety: A Network Meta-Analysis of Randomized Controlled Trials

AHA Scientific Sessions 2025 Abstract

The paper

Lokman Hekim Tanrıverdi, Muhammed Melih Dogan, Angela Su,
Show 2 more authorsRyan M. Shan, Maciej Banach,
Adrián Vladimir Hernández

Inonu University · University of Connecticut

AHA Scientific Sessions 2025 Abstract · 3 Nov 2025

Presented at AHA Scientific Sessions 2025 · Abstract 4348302

doi.org/10.1161/circ.152.suppl_3.4348302